Search Medical Condition
Please enter condition
Please choose location from dropdown

Oulu, Finland Clinical Trials

A listing of Oulu, Finland clinical trials actively recruiting patients volunteers.

RESULTS

Found (76) clinical trials

Synthetic vs Natural Estrogen in Combined Oral Contraception

The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of ...

Phase

0.0 miles

Learn More »

Cerebellar Mutism Syndrome Study

Background Cancer accounts for 22 % of all deaths among children in Europe and is thus the leading non-traumatic pediatric cause of death. Central nervous system (CNS) tumours constitute 25% of all childhood cancers, and the majority of these are located in the posterior fossa. One of the most troublesome ...

Phase N/A

0.0 miles

Learn More »

Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax ) to the Drug (Everolimus) -Eluting Stent (Synergy ) in Acute Coronary Syndrome

Coronary artery disease (CAD) is the most frequent cause of death, accounting for approximately 13% of all deaths. In western countries, the incidence of ST-segment elevation myocardial infarction (STEMI) is around 77/100 000/year, whereas in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), the incidence is 132/100 000/year. Thus, the ...

Phase

0.0 miles

Learn More »

Outcome After Coronary Artery Bypass Grafting

Improvements in the surgical treatment of coronary artery disease are possible only when implementation of current methods and development of new methods are based on the solid ground of large and reliable clinical data. Furthermore, clinical findings assume even more significance when detected in study populations from different institutions with ...

Phase N/A

0.0 miles

Learn More »

Comparison of Mini Gastric Bypass and Roux-en-Y Gastric Bypass

Roux-en-Y gastric bypass (RYGB) and single anastomosis gastric bypass (SAGB or mini gastric bypass, MGB) have both shown excellent weight-loss and effect on comorbidities such as type 2 diabetes. In this study eligible patients are randomized for either of the operations. Effects on glucose homeostasis as well as weight-loss and ...

Phase N/A

0.0 miles

Learn More »

The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients

Background: Globally, 15% of the population is affected by migraines at some point in their life-time. Pprophylactic treatment of migraines is an important part of the total management of migraine patients, having twofold goals: i) to reduce the frequency, painfulness, and/or duration of migraines, and ii) to increase the effectiveness ...

Phase N/A

0.0 miles

Learn More »

Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture

For some of the patients RA may be even more safe than GA. According to a large meta-analysis RA reduces the risk of several complications versus GA. Risk of deep vein thrombosis is reduced by 44% Risk of pulmonary embolism is reduced by 55 % Risk of major bleeding is ...

Phase N/A

0.0 miles

Learn More »

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

The REFINE ICD trial will assess whether prophylactic ICD therapy, guided by non-invasive risk assessment tools, reduces mortality in MI survivors with better-preserved LV function.

Phase

0.0 miles

Learn More »

Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome

The study population consists of women of reproductive age with PCOS, no wish of pregnancy and no other contraindications to hormonal contraceptives. The volunteer subjects will be recruited from hospital's patient files with PCOS (IC diagnosis E.28.2). Methods Sample size Our previous study comparing the metabolic effects of the same ...

Phase

0.0 miles

Learn More »

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

GAST-TaxXel is an open, phase II, single arm, non-randomized, Finnish multicenter trial. At least 50 subjects will be enrolled. Primary endpoint: To determine the quality of life (EORTC QLQ-C30 and QLQ-STO22) in patients with gastric cancer who receive combination treatment with Taxotere and Xeloda. Secondary endpoint: To evaluate time to ...

Phase

0.0 miles

Learn More »